Literature DB >> 8526143

Vaccine adjuvancy: a new potential area of development for GM-CSF.

M Taglietti1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526143     DOI: 10.1007/978-1-4615-1971-3_127

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  1 in total

1.  Granulocyte-macrophage colony-stimulating factor given as an adjuvant to persons not responding to hepatitis B vaccine.

Authors:  T Carlsson; J Struve
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.